Clinical trial
Intravaginal LACTIN-V for Prevention of Recurrent Urinary Tract Infection
NCT00305227 · University of Washington, Other · Completed
Key facts
| NCT number | NCT00305227 |
|---|---|
| Title | Intravaginal LACTIN-V for Prevention of Recurrent Urinary Tract Infection |
| Official title | Intravaginal LACTIN-V for Prevention of Recurrent Urinary Tract Infections |
| Lead sponsor | University of Washington, Other |
| Collaborators | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NIH Osel, Inc. Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Urinary Tract Infection |
| Intervention type | Drug |
| Interventions | Lactin-V, Placebo |
| Enrollment | 100 |
| Start date | Mar 1, 2006 |
| Primary completion | Apr 1, 2012 |
| Completion | Apr 1, 2012 |
| First posted | Mar 21, 2006 |
| Last update posted | Apr 14, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: